DR. DAVID M BAKER MD NPI 1063464279

NPI Details

DR. David M Baker, MD is a cardiovascular disease internal medicine in Carson City, NV with 31 years of experience. The provider is an internist who specializes in diseases of the heart and blood vessels and manages complex cardiac conditions such as heart attacks and life-threatening, abnormal heartbeat rhythms. DR. David M Baker, MD NPI is 1063464279. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1995

The provider's business location address is:

1470 MEDICAL PKWY
SUITE 160
CARSON CITY, NV
ZIP 89703-648
Phone: (775) 445-7650
Fax: (775) 687-8457

The NPI 1063464279 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Coronavirus vaccine 14 (HCPCS:91313)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only (HCPCS:93010)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Sarscov2 vac 50mcg/0.25ml im (HCPCS:91306)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Anticoagulant management of patient taking warfarin (HCPCS:93793)
• Nuclear medicine studies of heart muscle at rest and with stress and spect (HCPCS:78452)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Ultrasound of heart with color-depicted blood flow, rate and valve function (HCPCS:93325)
• Ultrasound of heart, follow-up (HCPCS:93308)
• Ultrasound of heart blood flow, valves and chambers, follow-up (HCPCS:93321)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage, for intramuscular use (HCPCS:91301)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; first dose (HCPCS:0011A)
• Initial hospital observation care per day, typically 50 minutes (HCPCS:99219)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• External shock to heart to regulate heart beat (HCPCS:92960)
• Ultrasound of heart with probe in esophagus, with report (HCPCS:93312)
• Programming of dual lead pacemaker system (HCPCS:93280)
• Evaluation of single, dual, multiple lead or leadless pacemaker system (HCPCS:93288)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose (HCPCS:0012A)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Follow-up observation care per day, typically 25 minutes (HCPCS:99225)
• Emergency department visit for problem of high severity (HCPCS:99284)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, dna, spike protein, adenovirus type 26 (ad26) vector, preservative free, 5x1010 viral particles/0.5ml dosage, for intramuscular use (HCPCS:91303)
• Ultrasound of heart, follow-up (HCPCS:93308)
• Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician (HCPCS:93016)
• Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician (HCPCS:93018)
• Ultrasound of heart during rest, exercise and/or drug-induced stress with report (HCPCS:93350)

The enumeration date for this NPI number is 5/16/2006 and was last updated on 3/14/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.